Honoka Kiso, CEO, spoke at an event hosted by Nakanoshima Qross Drug Discovery and Commercialisation

Spoke at a seminar entitled "A Thorough Analysis of the Pitfalls of Drug Discovery Startups: Practical Knowledge to Overcome. Them with Limited Resources (Drug Discovery Cluster Campus Project)" under the theme of "Social implementation of regenerative medical care and the role of startups".
Shared specific examples of the progress of research and development of tooth regenerative drugs and the challenges as a drug discovery venture.
We will keep contributing to solve social issues through the practical application of innovative regenerative drugs.

For more information, please visit
https://www.nakanoshima-qross.jp/news/2742/